Free Trial
OTCMKTS:BNKL

Bionik Laboratories (BNKL) Stock Price, News & Analysis

Bionik Laboratories logo

About Bionik Laboratories Stock (OTCMKTS:BNKL)

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
7 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Bionik Laboratories Corp. was a medical technology company focused on robotic rehabilitation systems for people recovering from neurological and physical impairments. Its products were designed primarily for use in hospitals, rehabilitation centers and other clinical settings.

The company’s principal product line was the InMotion robotic therapy platform, which included systems intended to support repetitive, adaptive rehabilitation of the arm, hand and shoulder. The technology was developed to assist therapists in treating patients affected by stroke and other conditions that impair upper-extremity movement.

Bionik marketed its rehabilitation systems to healthcare providers in North America and other international markets. Publicly available information about the company’s current operations and leadership is limited, and its historical product and corporate information is more readily available than details about its present business activities.

AI Generated. May Contain Errors.

Receive BNKL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bionik Laboratories and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

BNKL Stock News Headlines

BNKL Bionik Laboratories Corp.
Bionik Laboratories Corp.
A dividend every week of the year
Most dividend stocks pay quarterly, leaving long stretches of silence between paydays. For investors covering real expenses, that rhythm rarely lines up with the bills. Nathan Slaughter, Chief Investment Strategist at High-Yield Investing, built a full 52-week calendar by sequencing quality dividend payers so every week is covered, including bonus dividends that cluster from December through February.tc pixel
BMND:CA Biomind Labs Inc.
Silicon Laboratories Inc.
First human eggs grown in laboratory
See More Headlines

BNKL Stock Analysis - Frequently Asked Questions

Shares of BNKL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Bionik Laboratories investors own include Ashford Hospitality Trust (AHT), Assertio (ASRT), Peabody Energy (BTU), Co-Diagnostics (CODX), Ardmore Shipping (ASC).

Company Calendar

Today
10/06/2026
Fiscal Year End
3/31/2027

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Healthcare Equipment & Supplies
Sub-Industry
Healthcare Equipment
Current Symbol
OTCMKTS:BNKL
CIK
1508381
Fax
N/A
Employees
10
Year Founded
2009

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A

Social Links

Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

This page (OTCMKTS:BNKL) was last updated on 10/6/2026 by MarketBeat.com Staff.
From Our Partners